These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1666771)

  • 1. Endogenous 211At alpha-particle radiotherapy for undifferentiated thyroid cancer.
    Brown I; Carpenter RN
    Acta Radiol Suppl; 1991; 376():174-5. PubMed ID: 1666771
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
    Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
    J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers.
    Vaidyanathan G; Boskovitz A; Shankar S; Zalutsky MR
    Peptides; 2004 Dec; 25(12):2087-97. PubMed ID: 15572196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.
    Link EM; Carpenter RN
    Cancer Res; 1990 May; 50(10):2963-7. PubMed ID: 2334899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.
    Link EM; Carpenter RN
    Cancer Res; 1992 Aug; 52(16):4385-90. PubMed ID: 1643635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate.
    Zalutsky MR; Stabin MG; Larsen RH; Bigner DD
    Nucl Med Biol; 1997 Apr; 24(3):255-61. PubMed ID: 9228660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.
    Zalutsky MR; McLendon RE; Garg PK; Archer GE; Schuster JM; Bigner DD
    Cancer Res; 1994 Sep; 54(17):4719-25. PubMed ID: 8062270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
    Link EM; Michalowski AS; Rösch F
    Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histopathological study of subcutaneous heterograft of human gastric cancer in nude mice treated with 211At labelled monoclonal antibody].
    Luo DY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):23-5. PubMed ID: 8334936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a [211At]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies.
    Brown I; Mitchell JS
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):115-24. PubMed ID: 8175418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the in vivo stability of different kinds of 211At-labeled particles].
    Wunderlich G; Fischer S; Franke WG; Dreyer R
    Radiobiol Radiother (Berl); 1988; 29(2):212-4. PubMed ID: 3399660
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative concentration of astatine-211 and iodine-125 by human fetal thyroid and carcinoma of the thyroid in nude mice.
    Cobb LM; Harrison A; Dudley NE; Carr TE; Humphreys JA
    Radiother Oncol; 1988 Nov; 13(3):203-9. PubMed ID: 3222465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.
    Zalutsky MR; Vaidyanathan G
    Curr Pharm Des; 2000 Sep; 6(14):1433-55. PubMed ID: 10903402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of free 211At and 125I- in nude mice bearing tumors derived from anaplastic thyroid carcinoma cell lines.
    Lundh C; Lindencrona U; Schmitt A; Nilsson M; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2006 Dec; 21(6):591-600. PubMed ID: 17257074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein.
    Talanov VS; Garmestani K; Regino CA; Milenic DE; Plascjak PS; Waldmann TA; Brechbiel MW
    Nucl Med Biol; 2006 May; 33(4):469-80. PubMed ID: 16720238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
    Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.
    Palm S; Bäck T; Claesson I; Danielsson A; Elgqvist J; Frost S; Hultborn R; Jensen H; Lindegren S; Jacobsson L
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):572-9. PubMed ID: 17869670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The curative and palliative potential of the monoclonal antibody MOv18 labelled with 211At in nude mice with intraperitoneally growing ovarian cancer xenografts--a long-term study.
    Andersson H; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Acta Oncol; 2000; 39(6):741-5. PubMed ID: 11130014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.